Skip to main content

. 1988 Jul 9;297(6641):110–111. doi: 10.1136/bmj.297.6641.110

The serotonin type 3 receptor antagonist BRL 43694 and nausea and vomiting induced by cisplatin.

J Carmichael ¹, B M Cantwell ¹, C M Edwards ¹, W G Rapeport ¹, A L Harris ¹

PMCID: PMC1833825 PMID: 2841996

110

Images in this article

p111-a
on p.111

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

Bateman D. N., Rawlins M. D., Simpson J. M. Extrapyramidal reactions with metoclopramide. Br Med J (Clin Res Ed) 1985 Oct 5;291(6500):930–932. doi: 10.1136/bmj.291.6500.930. [DOI] [PMC free article] [PubMed] [Google Scholar]
Cunningham D., Hawthorn J., Pople A., Gazet J. C., Ford H. T., Challoner T., Coombes R. C. Prevention of emesis in patients receiving cytotoxic drugs by GR38032F, a selective 5-HT3 receptor antagonist. Lancet. 1987 Jun 27;1(8548):1461–1463. doi: 10.1016/s0140-6736(87)92208-2. [DOI] [PubMed] [Google Scholar]
Fozard J. R., Mobarok ALI A. T. Blockade of neuronal tryptamine receptors by metoclopramide. Eur J Pharmacol. 1978 May 1;49(1):109–112. doi: 10.1016/0014-2999(78)90228-5. [DOI] [PubMed] [Google Scholar]
Kris M. G., Gralla R. J., Clark R. A., Tyson L. B., O'Connell J. P., Wertheim M. S., Kelsen D. P. Incidence, course, and severity of delayed nausea and vomiting following the administration of high-dose cisplatin. J Clin Oncol. 1985 Oct;3(10):1379–1384. doi: 10.1200/JCO.1985.3.10.1379. [DOI] [PubMed] [Google Scholar]

ACTIONS

RESOURCES